Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells
(Q57105861)
Language:
Current Data About
Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells
| (P31) |
(Q13442814)
|
||||||||||||||
| (P304) |
5421-5
|
||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||
| (P433) |
17
|
||||||||||||||
| (P478) |
50
|
||||||||||||||
| (P577) |
Saturday, September 1, 1990
|
||||||||||||||
| (P921) |
(Q194908)
(Q79460)
(Q422248)
|
||||||||||||||
| (P1433) |
(Q326097)
|
||||||||||||||
| (P1476) |
"Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells" (language: en)
|
||||||||||||||
| (P2093) |
K R Schultz
J P Klarnet
D J Peace
M A Cheever
C C Badger
I D Bernstein
P D Greenberg
|